After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
Indian cricketer Hardik Pandya is in the news for his personal life. There are reports of turmoil
Ban on Wheat Export: Wheat is not cheaper than export ban, only 54 paise relief in 12 days
Despite the ban on the export of wheat, its prices in the domestic market are not coming down. Wh
India had to face defeat in the second ODI against Bangladesh. With this victory, Bangladesh has
Noida [Mohammad Bilal]. After Delhi, night curfew has also been announced in Ghaziabad and Noida-
On Friday, PM Modi inaugurated the Global Investor Summit-2023 in Lucknow. During this, he mentio
During the coming festivals, the Pakistani conspiracy to blast the country has been exposed. Delh
Akshay Kumar starrer film Samrat Prithviraj had a special screening on Wednesday. The special gue
Police in Sindhudurg district of Maharashtra have registered a case against the contractor and st
Riots broke out in Mexico following the arrest of Ovidio Guzmán-López, the son of d
A major helicopter accident was averted on Friday during the Mata Vaishno Devi pilgrimage. A heli
